{"success":true,"data":{"pressRelease":{"id":"167550","rtpr_id":"nGNX6p1Z4W-20261013","ticker":"RWAY","exchange":"NASDAQ","all_tickers":["RWAY"],"title":"Runway Growth Finance Corp. Provides Third Quarter 2026 Portfolio Update","author":"Globe Newswire","published_at":"2026-10-13T12:30:00.242Z","article_body":"MENLO PARK, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance\nCorp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading\nprovider of flexible capital solutions to late- and growth-stage companies\nseeking an alternative to raising equity, today provided an operational and\nportfolio update for the quarter ended September 30, 2026.\n\n“During the third quarter of 2026, with our expanded leadership team in\nplace, we remained focused on optimizing the portfolio and allocating capital\nin a manner that we believe best serves our shareholders,” said Runway\nGrowth Founder and Co-CEO David Spreng. “We continue to take a measured\napproach to new originations while remaining optimistic about Runway’s\nlong-term growth opportunity and confident in our ability to capitalize on the\nexpanding financing needs of the innovation economy.”\n\n“We continued to make progress this quarter optimizing our portfolio, which\nwe believe is one of the most important ways we can create value for\nshareholders,” said Runway Growth Co-CEO Michael Rovner. “We are\nencouraged by the healthy level of repayment activity, which we believe\nreflects the underlying strength of many of our portfolio companies. As we\nnoted earlier this quarter, we believe Runway’s share price does not\naccurately reflect the fundamentals of our portfolio. We remain focused on\nclosing that valuation gap over time through disciplined capital deployment,\nincluding share repurchases and selective new originations.”\n\nOriginations\n\nDuring the third quarter of 2026, Runway Growth funded follow-on investments\nin four existing portfolio companies totaling approximately $8.5 million.\nThese included:\n* Completion of follow-on investments in an aggregate amount of $2.9 million\nto three existing portfolio companies;\n* Restructure of approximately $28.9 million in unfunded commitments to Marley\nSpoon SE into a €8.1 million bridge loan, of which approximately $5.6\nmillion was funded during the quarter.\nMarley Spoon remains under active portfolio management. The portfolio company\nis advancing a revised operating plan focused on reducing costs and achieving\nfinancial sustainability, which includes a recently announced 21% workforce\nreduction. Runway remains actively engaged as the restructuring process\nevolves and continues to evaluate multiple paths to liquidity.\n\nLiquidity Events\n\nDuring the third quarter of 2026, Runway Growth experienced the following\nliquidity events totaling $139.4 million in its investment portfolio:\n* Full repayment of the Company's senior secured term loan to 3PL Central LLC\n(dba Extensiv) of $72.3 million;\n* Full repayment of the Company's senior secured term loan to Route 92\nMedical, Inc. of $35.0 million;\n* Full repayment of the Company's senior secured term loan to Onward Medical,\nN.V. of $17.1 million;\n* Full repayment of the Company's senior secured term loan to Shepherd\nIntermediate, LLC (dba Federal Hearings and Appeals Services) of $6.3 million;\nand\n* Other scheduled loan principal amortization payments and partial prepayments\nof $8.7 million.\nPortfolio Construction and Management\n\nRunway Growth is a credit-first organization, carefully structured to focus on\nwhat it believes to be the highest-quality, late-stage companies in the\nventure debt market. The Company seeks to uphold industry-leading investment\nstandards as well as disciplined underwriting and monitoring of its portfolio.\nRunway Growth is positioned as a preferred lender in the venture debt space,\nsupporting and working closely with companies to help them reach their full\ngrowth potential. Since inception, the Company has focused on the fastest\ngrowing sectors of the economy, including healthcare, technology and select\nconsumer services and products industries.\n\nAs of September 30, 2026, the Runway Growth portfolio included 52 debt\ninvestments to 42 companies and 102 equity investments in 66 companies,\nincluding 31 companies where Runway Growth holds both a debt and equity\ninvestment. Investments were comprised of late and growth-stage businesses in\nthe technology, healthcare and select consumer services and products\nindustries. Runway Growth’s normal business operations include frequent\ncommunication with portfolio companies.\n\nAbout Runway Growth Finance Corp.\n\nRunway Growth is a specialty finance company focused on providing flexible\ncapital solutions to late- and growth-stage companies seeking an alternative\nto raising equity. Runway Growth is a closed-end investment fund that has\nelected to be regulated as a business development company under the Investment\nCompany Act of 1940, as amended. Runway Growth is externally managed by Runway\nGrowth Capital LLC, an affiliate of BC Partners Advisors L.P., and led by\nindustry veterans David Spreng and Michael Rovner. For more information,\nplease visit www.runwaygrowth.com.\n\nForward-Looking Statements\n\nStatements included herein may constitute \"forward-looking statements\" within\nthe meaning of the Private Securities Litigation Reform Act of 1995, as\namended. Statements other than statements of historical facts included in this\npress release may constitute forward-looking statements and are not guarantees\nof future performance, condition or results and involve a number of risks and\nuncertainties. Actual results may differ materially from those in\nforward-looking statements as a result of a number of factors, including those\ndescribed from time to time in Runway Growth’s filings with the Securities\nand Exchange Commission. Runway Growth undertakes no duty to update any\nforward-looking statement made herein. All forward-looking statements speak\nonly as of the date of this press release.\n\nNo Offer or Solicitation\n\nThis press release is not, and under no circumstances is it to be construed\nas, a prospectus or an advertisement and the communication of this press\nrelease is not, and under no circumstances is it to be construed as, an offer\nto sell or a solicitation of an offer to purchase any securities in Runway\nGrowth or in any fund or other investment vehicle managed by Runway Growth\nCapital LLC, BC Partners Advisors L.P. or any of their affiliates.\n\nImportant Disclosures\n\nStrategies described in this press release involve special risks that should\nbe evaluated carefully before a decision is made to invest. Not all of the\nrisks and other significant aspects of these strategies are discussed herein.\nPlease see a more detailed discussion of these risk factors and other related\nrisks in the Company’s most recent annual report on Form 10-K in the section\nentitled “Risk Factors”, which may be obtained on the Company’s website,\nwww.runwaygrowth.com, or the SEC’s website, www.sec.gov.\n\nIR Contacts \n\nTaylor Donahue, Prosek Partners, rway@prosek.com\n\nCarmela Thomson, Chief Financial Officer, ct@runwaygrowth.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/d2006d07-f2cf-4a05-b037-1bdf72b42765)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX6p1Z4W-20261013","title":"Runway Growth Finance Corp. Provides Third Quarter 2026 Portfolio Update","author":"Globe Newswire","ticker":"RWAY","created":"2026-10-13T12:30:00.242Z","tickers":["RWAY"],"exchange":"NASDAQ","article_body":"MENLO PARK, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance\nCorp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading\nprovider of flexible capital solutions to late- and growth-stage companies\nseeking an alternative to raising equity, today provided an operational and\nportfolio update for the quarter ended September 30, 2026.\n\n“During the third quarter of 2026, with our expanded leadership team in\nplace, we remained focused on optimizing the portfolio and allocating capital\nin a manner that we believe best serves our shareholders,” said Runway\nGrowth Founder and Co-CEO David Spreng. “We continue to take a measured\napproach to new originations while remaining optimistic about Runway’s\nlong-term growth opportunity and confident in our ability to capitalize on the\nexpanding financing needs of the innovation economy.”\n\n“We continued to make progress this quarter optimizing our portfolio, which\nwe believe is one of the most important ways we can create value for\nshareholders,” said Runway Growth Co-CEO Michael Rovner. “We are\nencouraged by the healthy level of repayment activity, which we believe\nreflects the underlying strength of many of our portfolio companies. As we\nnoted earlier this quarter, we believe Runway’s share price does not\naccurately reflect the fundamentals of our portfolio. We remain focused on\nclosing that valuation gap over time through disciplined capital deployment,\nincluding share repurchases and selective new originations.”\n\nOriginations\n\nDuring the third quarter of 2026, Runway Growth funded follow-on investments\nin four existing portfolio companies totaling approximately $8.5 million.\nThese included:\n* Completion of follow-on investments in an aggregate amount of $2.9 million\nto three existing portfolio companies;\n* Restructure of approximately $28.9 million in unfunded commitments to Marley\nSpoon SE into a €8.1 million bridge loan, of which approximately $5.6\nmillion was funded during the quarter.\nMarley Spoon remains under active portfolio management. The portfolio company\nis advancing a revised operating plan focused on reducing costs and achieving\nfinancial sustainability, which includes a recently announced 21% workforce\nreduction. Runway remains actively engaged as the restructuring process\nevolves and continues to evaluate multiple paths to liquidity.\n\nLiquidity Events\n\nDuring the third quarter of 2026, Runway Growth experienced the following\nliquidity events totaling $139.4 million in its investment portfolio:\n* Full repayment of the Company's senior secured term loan to 3PL Central LLC\n(dba Extensiv) of $72.3 million;\n* Full repayment of the Company's senior secured term loan to Route 92\nMedical, Inc. of $35.0 million;\n* Full repayment of the Company's senior secured term loan to Onward Medical,\nN.V. of $17.1 million;\n* Full repayment of the Company's senior secured term loan to Shepherd\nIntermediate, LLC (dba Federal Hearings and Appeals Services) of $6.3 million;\nand\n* Other scheduled loan principal amortization payments and partial prepayments\nof $8.7 million.\nPortfolio Construction and Management\n\nRunway Growth is a credit-first organization, carefully structured to focus on\nwhat it believes to be the highest-quality, late-stage companies in the\nventure debt market. The Company seeks to uphold industry-leading investment\nstandards as well as disciplined underwriting and monitoring of its portfolio.\nRunway Growth is positioned as a preferred lender in the venture debt space,\nsupporting and working closely with companies to help them reach their full\ngrowth potential. Since inception, the Company has focused on the fastest\ngrowing sectors of the economy, including healthcare, technology and select\nconsumer services and products industries.\n\nAs of September 30, 2026, the Runway Growth portfolio included 52 debt\ninvestments to 42 companies and 102 equity investments in 66 companies,\nincluding 31 companies where Runway Growth holds both a debt and equity\ninvestment. Investments were comprised of late and growth-stage businesses in\nthe technology, healthcare and select consumer services and products\nindustries. Runway Growth’s normal business operations include frequent\ncommunication with portfolio companies.\n\nAbout Runway Growth Finance Corp.\n\nRunway Growth is a specialty finance company focused on providing flexible\ncapital solutions to late- and growth-stage companies seeking an alternative\nto raising equity. Runway Growth is a closed-end investment fund that has\nelected to be regulated as a business development company under the Investment\nCompany Act of 1940, as amended. Runway Growth is externally managed by Runway\nGrowth Capital LLC, an affiliate of BC Partners Advisors L.P., and led by\nindustry veterans David Spreng and Michael Rovner. For more information,\nplease visit www.runwaygrowth.com.\n\nForward-Looking Statements\n\nStatements included herein may constitute \"forward-looking statements\" within\nthe meaning of the Private Securities Litigation Reform Act of 1995, as\namended. Statements other than statements of historical facts included in this\npress release may constitute forward-looking statements and are not guarantees\nof future performance, condition or results and involve a number of risks and\nuncertainties. Actual results may differ materially from those in\nforward-looking statements as a result of a number of factors, including those\ndescribed from time to time in Runway Growth’s filings with the Securities\nand Exchange Commission. Runway Growth undertakes no duty to update any\nforward-looking statement made herein. All forward-looking statements speak\nonly as of the date of this press release.\n\nNo Offer or Solicitation\n\nThis press release is not, and under no circumstances is it to be construed\nas, a prospectus or an advertisement and the communication of this press\nrelease is not, and under no circumstances is it to be construed as, an offer\nto sell or a solicitation of an offer to purchase any securities in Runway\nGrowth or in any fund or other investment vehicle managed by Runway Growth\nCapital LLC, BC Partners Advisors L.P. or any of their affiliates.\n\nImportant Disclosures\n\nStrategies described in this press release involve special risks that should\nbe evaluated carefully before a decision is made to invest. Not all of the\nrisks and other significant aspects of these strategies are discussed herein.\nPlease see a more detailed discussion of these risk factors and other related\nrisks in the Company’s most recent annual report on Form 10-K in the section\nentitled “Risk Factors”, which may be obtained on the Company’s website,\nwww.runwaygrowth.com, or the SEC’s website, www.sec.gov.\n\nIR Contacts \n\nTaylor Donahue, Prosek Partners, rway@prosek.com\n\nCarmela Thomson, Chief Financial Officer, ct@runwaygrowth.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/d2006d07-f2cf-4a05-b037-1bdf72b42765)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-13T12:30:00.292866055Z","server_sent_at_ms":1791894600292},"received_at":"2026-10-13T12:30:00.444Z","source_url":null},"analysis":{"id":"155852","press_release_id":"167550","analysis_json":{"industry":{"label":"Capital Markets","sector":"Financials"},"redFlags":["Marley Spoon exposure restructured into bridge loan; borrower undergoing restructuring with 21% workforce reduction"],"eventType":"operations_update","narrative":"Runway Growth Finance recorded $139.4 million of liquidity events in Q3 2026, including full repayment of loans to Extensiv ($72.3M), Route 92 Medical ($35.0M), Onward Medical ($17.1M) and Shepherd Intermediate ($6.3M).\n\nThe company also restructured roughly $28.9 million in unfunded commitments to Marley Spoon into a €8.1 million bridge loan, with Marley Spoon advancing a cost-cutting plan including a 21% workforce reduction.\n\nNew originations were modest at approximately $8.5 million of follow-on investments, consistent with management's measured deployment stance, and management reiterated its view that the share price understates portfolio fundamentals, supported by buybacks.","sentiment":"mixed","agentHooks":{"shouldPost":false,"suggestedAngle":"Strong Q3 repayment activity ($139.4M) offsets watch-list Marley Spoon exposure ahead of full earnings."},"keyFigures":{"customDimensions":{"liquidity_events":"$139.4 million total repayments in Q3 2026","extensiv_repayment":"$72.3 million","shepherd_repayment":"$6.3 million","portfolio_composition":"52 debt investments in 42 companies; 102 equity investments in 66 companies","follow_on_originations":"$8.5 million in follow-on investments to four existing portfolio companies","marley_spoon_restructure":"approx. $28.9M unfunded commitments restructured into €8.1M bridge loan","onward_medical_repayment":"$17.1 million","route_92_medical_repayment":"$35.0 million"}},"quotedText":"We are encouraged by the healthy level of repayment activity, which we believe reflects the underlying strength of many of our portfolio companies.","namedEntities":{"people":[{"name":"David Spreng","role":"Founder and Co-CEO"},{"name":"Michael Rovner","role":"Co-CEO"},{"name":"Carmela Thomson","role":"Chief Financial Officer"}],"products":[],"companies":[{"name":"Runway Growth Finance Corp.","ticker":"RWAY","relationship":"filer"},{"name":"Marley Spoon SE","relationship":"portfolio company (restructured exposure, distressed)"},{"name":"3PL Central LLC (dba Extensiv)","relationship":"portfolio company (loan repaid)"},{"name":"Route 92 Medical, Inc.","relationship":"portfolio company (loan repaid)"},{"name":"Onward Medical, N.V.","relationship":"portfolio company (loan repaid)"},{"name":"Shepherd Intermediate, LLC","relationship":"portfolio company (loan repaid)"},{"name":"Runway Growth Capital LLC","relationship":"external manager"},{"name":"BC Partners Advisors L.P.","relationship":"affiliate of external manager"}],"dollarAmounts":[{"amount":"$139.4 million","context":"total Q3 2026 liquidity events/repayments"},{"amount":"$8.5 million","context":"follow-on investments in four existing portfolio companies"},{"amount":"$28.9 million","context":"restructured Marley Spoon unfunded commitments"},{"amount":"€8.1 million","context":"Marley Spoon bridge loan"},{"amount":"$72.3 million","context":"repayment by 3PL Central/Extensiv"},{"amount":"$35.0 million","context":"repayment by Route 92 Medical"},{"amount":"$17.1 million","context":"repayment by Onward Medical"},{"amount":"$6.3 million","context":"repayment by Shepherd Intermediate"},{"amount":"$8.7 million","context":"scheduled amortization and partial prepayments"}]},"materialImpact":{"score":2,"reasoning":"Pre-earnings portfolio update with strong $139.4M in repayments, but includes a restructured $28.9M unfunded commitment to distressed portfolio company Marley Spoon. Operational color only; full financials not yet reported."},"tickerRelevance":{"others":[],"primary":"RWAY"},"globalImportance":25,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap BDC","creditSignal":"distressed Marley Spoon restructuring vs. strong repayments","eventGravity":"pre-earnings portfolio update"}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"mixed","material_impact_score":2,"narrative":"Runway Growth Finance recorded $139.4 million of liquidity events in Q3 2026, including full repayment of loans to Extensiv ($72.3M), Route 92 Medical ($35.0M), Onward Medical ($17.1M) and Shepherd Intermediate ($6.3M).\n\nThe company also restructured roughly $28.9 million in unfunded commitments to Marley Spoon into a €8.1 million bridge loan, with Marley Spoon advancing a cost-cutting plan including a 21% workforce reduction.\n\nNew originations were modest at approximately $8.5 million of follow-on investments, consistent with management's measured deployment stance, and management reiterated its view that the share price understates portfolio fundamentals, supported by buybacks.","key_figures":{"customDimensions":{"liquidity_events":"$139.4 million total repayments in Q3 2026","extensiv_repayment":"$72.3 million","shepherd_repayment":"$6.3 million","portfolio_composition":"52 debt investments in 42 companies; 102 equity investments in 66 companies","follow_on_originations":"$8.5 million in follow-on investments to four existing portfolio companies","marley_spoon_restructure":"approx. $28.9M unfunded commitments restructured into €8.1M bridge loan","onward_medical_repayment":"$17.1 million","route_92_medical_repayment":"$35.0 million"}},"named_entities":{"people":[{"name":"David Spreng","role":"Founder and Co-CEO"},{"name":"Michael Rovner","role":"Co-CEO"},{"name":"Carmela Thomson","role":"Chief Financial Officer"}],"products":[],"companies":[{"name":"Runway Growth Finance Corp.","ticker":"RWAY","relationship":"filer"},{"name":"Marley Spoon SE","relationship":"portfolio company (restructured exposure, distressed)"},{"name":"3PL Central LLC (dba Extensiv)","relationship":"portfolio company (loan repaid)"},{"name":"Route 92 Medical, Inc.","relationship":"portfolio company (loan repaid)"},{"name":"Onward Medical, N.V.","relationship":"portfolio company (loan repaid)"},{"name":"Shepherd Intermediate, LLC","relationship":"portfolio company (loan repaid)"},{"name":"Runway Growth Capital LLC","relationship":"external manager"},{"name":"BC Partners Advisors L.P.","relationship":"affiliate of external manager"}],"dollarAmounts":[{"amount":"$139.4 million","context":"total Q3 2026 liquidity events/repayments"},{"amount":"$8.5 million","context":"follow-on investments in four existing portfolio companies"},{"amount":"$28.9 million","context":"restructured Marley Spoon unfunded commitments"},{"amount":"€8.1 million","context":"Marley Spoon bridge loan"},{"amount":"$72.3 million","context":"repayment by 3PL Central/Extensiv"},{"amount":"$35.0 million","context":"repayment by Route 92 Medical"},{"amount":"$17.1 million","context":"repayment by Onward Medical"},{"amount":"$6.3 million","context":"repayment by Shepherd Intermediate"},{"amount":"$8.7 million","context":"scheduled amortization and partial prepayments"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-13T12:30:08.773Z","global_importance":25,"audience_relevance":25,"importance_components":{"tickerTier":"small-cap BDC","creditSignal":"distressed Marley Spoon restructuring vs. strong repayments","eventGravity":"pre-earnings portfolio update"}},"durationMs":8311,"modelName":"glm-5.3-flashx"}}